These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 36696570)

  • 1. Biomaterials-Mediated Engineering of the Immune System.
    Backlund C; Jalili-Firoozinezhad S; Kim B; Irvine DJ
    Annu Rev Immunol; 2023 Apr; 41():153-179. PubMed ID: 36696570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
    Ruan S; Huang Y; He M; Gao H
    Adv Sci (Weinh); 2022 May; 9(16):e2200027. PubMed ID: 35343112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
    Edwards C; Carey ST; Jewell CM
    ACS Appl Bio Mater; 2023 Jun; 6(6):2017-2028. PubMed ID: 37068126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the clinical impact of biomaterials in cancer immunotherapy.
    Gammon JM; Dold NM; Jewell CM
    Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterials as Tools to Decode Immunity.
    Eppler HB; Jewell CM
    Adv Mater; 2020 Apr; 32(13):e1903367. PubMed ID: 31782844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy.
    Dong Q; Xue T; Yan H; Liu F; Liu R; Zhang K; Chong Y; Du J; Zhang H
    J Nanobiotechnology; 2023 Oct; 21(1):395. PubMed ID: 37899463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.
    Demento SL; Siefert AL; Bandyopadhyay A; Sharp FA; Fahmy TM
    Trends Biotechnol; 2011 Jun; 29(6):294-306. PubMed ID: 21459467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Immune Tolerance with Biomaterials.
    Gammon JM; Jewell CM
    Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Vaccine and Immunotherapy Design Using Biomaterials.
    Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
    Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically active biomaterials for cancer therapy.
    Ali OA; Mooney DJ
    Curr Top Microbiol Immunol; 2011; 344():279-97. PubMed ID: 20556594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
    Lei K; Tang L
    Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomaterials for vaccine-based cancer immunotherapy.
    Zhang R; Billingsley MM; Mitchell MJ
    J Control Release; 2018 Dec; 292():256-276. PubMed ID: 30312721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Biomaterials Imaging Antitumor Immune Response.
    Ma X; Zhang MJ; Wang J; Zhang T; Xue P; Kang Y; Sun ZJ; Xu Z
    Adv Mater; 2022 Oct; 34(42):e2204034. PubMed ID: 35728795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring biomaterials for vaccine delivery.
    Zhuo Y; Zeng H; Su C; Lv Q; Cheng T; Lei L
    J Nanobiotechnology; 2024 Aug; 22(1):480. PubMed ID: 39135073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
    Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.